N-[[(氨基硫代甲酰)氨基]亚氨基甲基]-苯甲酰胺 | 63980-64-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-[[(氨基硫代甲酰)氨基]亚氨基甲基]-苯甲酰胺
• 英文名称: benzoylcarbamimidoyl-thiourea
• 英文别名: Benzoylcarbamimidoyl-thioharnstoff；Benzamide, N-(iminothioureidomethyl)-；N-[(E)-N'-carbamothioylcarbamimidoyl]benzamide
• CAS: 63980-64-3
• 化学式: C₉H₁₀N₄OS
• 分子量: 222.271
• InChiKey: BSRSEAYGGXWBAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  126
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  N-[[(氨基硫代甲酰)氨基]亚氨基甲基]-苯甲酰胺 在 乙醇 、 双氧水 作用下， 生成 3-氨基-5-苯基-1,2,4-噻二唑
  参考文献：
  名称：

  Review of the treatment literature for encopresis, functional constipation, and stool-toileting refusal

  摘要：

  This review summarizes the literature an randomized, controlled, published studies involving medical, behavioral, psychological, and biofeedback treatments for encopresis/functional constipation and stool-toileting refusal in preschool-age and school-age children. Nine such studies were located in the literature involving school-age children. No randomized controlled treatment studies involving preschool-age children have been published. This review revealed no evidence to support the routine Else of psychotherapy or anal sphincter biofeedback in the treatment of pediatric fecal elimination dysfunctions, beyond those benefits derived from a comprehensive medical-behavioral intervention. Further this review indicated that paradoxical constriction. of the External Anal Sphincter does not influence the treatment outcome of either biofeedback or medical-behavioral interventions. There are remarkably few controlled treatment outcome studies in this most important clinical area. More research is needed that employs standard treatment outcome variables.

  DOI：

  10.1007/bf02895121
• 作为产物：
  描述：

  N¹-benzoyl-N³-cyanoguanidine 在 乙醇 、 硫化氢 作用下， 生成 N-[[(氨基硫代甲酰)氨基]亚氨基甲基]-苯甲酰胺
  参考文献：
  名称：

  US2463819

  摘要：

  公开号：

文献信息

• Two-component initiator system (amine-free) with very good storage stability and particular suitability for acid systems
  申请人：Utterodt Andreas

  公开号：US20070040151A1

  公开（公告）日：2007-02-22

  A two-component initiator system having accelerators for curing polymerizable materials comprising the following components: (a) a hydroperoxide compound containing one or more hydroperoxide groups that are bound to a tertiary carbon; (b) a thiourea derivative; and (c) as accelerator, a copper compound which is soluble in the preparation is preferably free of amine and is particularly suited for polymerizable dental compositions.
• US2463819
  申请人：——

  公开号：——

  公开（公告）日：——
• Review of the treatment literature for encopresis, functional constipation, and stool-toileting refusal
  作者：Risa C. Brooks、Rachel M. Copen、Daniel J. Cox、James Morris、Stephen Borowitz、James Sutphen

  DOI：10.1007/bf02895121

  日期：2000.9

  This review summarizes the literature an randomized, controlled, published studies involving medical, behavioral, psychological, and biofeedback treatments for encopresis/functional constipation and stool-toileting refusal in preschool-age and school-age children. Nine such studies were located in the literature involving school-age children. No randomized controlled treatment studies involving preschool-age children have been published. This review revealed no evidence to support the routine Else of psychotherapy or anal sphincter biofeedback in the treatment of pediatric fecal elimination dysfunctions, beyond those benefits derived from a comprehensive medical-behavioral intervention. Further this review indicated that paradoxical constriction. of the External Anal Sphincter does not influence the treatment outcome of either biofeedback or medical-behavioral interventions. There are remarkably few controlled treatment outcome studies in this most important clinical area. More research is needed that employs standard treatment outcome variables.